首页> 外文期刊>Ecological restoration >Structure based docking and molecular dynamics studies: Peroxisome proliferator-activated receptors -alpha/gamma dual agonists for treatment of metabolic disorders
【24h】

Structure based docking and molecular dynamics studies: Peroxisome proliferator-activated receptors -alpha/gamma dual agonists for treatment of metabolic disorders

机译:基于结构的对接与分子动力学研究:过氧化物组织增殖物激活的受体 - 用于治疗代谢障碍的α/γ双激动剂

获取原文
获取原文并翻译 | 示例
           

摘要

Diabetes is a foremost health problem globally susceptible to increased mortality and morbidity. The present therapies in the antidiabetic class have sound adverse effects and thus, emphasis on the further need to develop effective medication therapy. Peroxisome proliferator-activated receptor alpha-gamma dual approach represents an interesting target for developing novel anti-diabetic drug along with potential anti-hyperlipidimic activity. In the current study, the peroxisome proliferator-activated receptor alpha-gamma agonistic hits were screened by hierarchical virtual screening of drug like compounds followed by molecular dynamics simulation and knowledge-based structure-activity relation analysis. The key amino acid residues of binding pockets of both target proteins were acknowledged as essential and were found to be associated in the key interactions with the most potential dual hit. This dual targeted approach of structure based computational technique was undertaken to identify prevalent promising hits for both targets with binding energy and absorption distribution metabolism excretion prediction supported the analysis of their pharmacokinetic potential. In addition, stability analysis using molecular dynamics simulation of the target protein complexes was performed with the most promising dual targeted hit found in this study. Further, comparative analysis of binding site of both targets was done for the development of knowledge-based structure-activity relationship, which may useful for successful designing of dual agonistic candidates.
机译:糖尿病是全球易受死亡率和发病率增加的最重要的健康问题。抗糖尿病类的目前疗法具有声音不利影响,从而强调进一步发展有效的药物治疗。过氧化物体增殖剂活化受体α-γ双方法代表了开发新型抗糖尿病药物以及潜在的抗高脂活性的有趣靶标。在目前的研究中,通过等化合物的分层虚拟筛选筛选过氧化物体增殖物激活的受体α-γ激动的击中,然后进行分子动力学模拟和基于知识的结构 - 活性关系分析。靶蛋白的结合袋的关键氨基酸残基作为必要性地确认,并发现与最潜在的双重击中的关键相互作用相关。这种基于结构的结构技术的双目标方法是对具有结合能量和吸收分布代谢排泄预测的普遍希望的普遍希望的令人兴奋的令人兴奋的命运支持预测其药代动力学的分析。此外,使用本研究中发现的最有前途的双重靶向击中,进行使用靶蛋白复合物的分子动力学模拟的稳定性分析。此外,对两个目标的结合位点进行了比较分析,为基于知识的结构 - 活动关系的发展完成,这可能有助于成功地设计双重激动主义候选人。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号